Trust Company of Kansas’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $392K | Sell |
2,111
-300
| -12% | -$55.7K | 0.19% | 38 |
|
|
2025
Q1 | $505K | Buy |
2,411
+300
| +14% | +$62.8K | 0.27% | 29 |
|
|
2024
Q4 | $375K | Sell |
2,111
-67
| -3% | -$11.9K | 0.18% | 37 |
|
|
2024
Q3 | $430K | Sell |
2,178
-10
| -0.5% | -$1.97K | 0.21% | 39 |
|
|
2024
Q2 | $375K | Buy |
2,188
+91
| +4% | +$15.6K | 0.2% | 36 |
|
|
2024
Q1 | $382K | Sell |
2,097
-100
| -5% | -$18.2K | 0.21% | 33 |
|
|
2023
Q4 | $340K | Sell |
2,197
-40
| -2% | -$6.19K | 0.19% | 35 |
|
|
2023
Q3 | $333K | Buy |
2,237
+201
| +10% | +$29.9K | 0.21% | 36 |
|
|
2023
Q2 | $274K | Sell |
2,036
-110
| -5% | -$14.8K | 0.16% | 39 |
|
|
2023
Q1 | $342K | Sell |
2,146
-208
| -9% | -$33.1K | 0.22% | 34 |
|
|
2022
Q4 | $380K | Sell |
2,354
-337
| -13% | -$54.4K | 0.25% | 38 |
|
|
2022
Q3 | $361K | Sell |
2,691
-261
| -9% | -$35K | 0.26% | 32 |
|
|
2022
Q2 | $452K | Sell |
2,952
-20
| -0.7% | -$3.06K | 0.27% | 30 |
|
|
2022
Q1 | $482K | Sell |
2,972
-35
| -1% | -$5.68K | 0.26% | 34 |
|
|
2021
Q4 | $407K | Sell |
3,007
-185
| -6% | -$25K | 0.22% | 39 |
|
|
2021
Q3 | $344K | Buy |
3,192
+38
| +1% | +$4.1K | 0.2% | 40 |
|
|
2021
Q2 | $355K | Sell |
3,154
-187
| -6% | -$21K | 0.2% | 37 |
|
|
2021
Q1 | $362K | Buy |
3,341
+1,057
| +46% | +$115K | 0.24% | 32 |
|
|
2020
Q4 | $245K | Sell |
2,284
-53,321
| -96% | -$5.72M | 0.13% | 40 |
|
|
2020
Q3 | $4.87M | Sell |
55,605
-8,433
| -13% | -$739K | 2.47% | 14 |
|
|
2020
Q2 | $6.29M | Buy |
64,038
+439
| +0.7% | +$43.1K | 3.48% | 12 |
|
|
2020
Q1 | $4.85M | Buy |
63,599
+5,624
| +10% | +$429K | 2.89% | 12 |
|
|
2019
Q4 | $5.13M | Buy |
+57,975
| New | +$5.13M | 3.01% | 17 |
|